Diagnosis and staging of cardiac masses: additional value of CMR with


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
06 2022
Historique:
received: 13 11 2021
accepted: 25 01 2022
pubmed: 6 3 2022
medline: 26 5 2022
entrez: 5 3 2022
Statut: ppublish

Résumé

Characterization of malignant cardiac masses is usually performed with cardiac magnetic resonance (CMR) and staging with whole-body contrast-enhanced computed tomography (CECT). In this study, our objective was to evaluate the role of Patients with cardiac masses who underwent CMR, CECT, and In a total of 28 patients (median age 60.5 years, 60.7% women), CMR accurately distinguished malignant from benign masses with sensitivity (Se) of 86.7%, specificity (Sp) of 100%, positive predictive value (PPV) of 100%, negative predictive value (NPV) of 86.7%, and accuracy of 92.9%. Combining

Identifiants

pubmed: 35247063
doi: 10.1007/s00259-022-05709-9
pii: 10.1007/s00259-022-05709-9
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2232-2241

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Bussani R, Castrichini M, Restivo L, Fabris E, Porcari A, Ferro F, et al. Cardiac tumors: diagnosis, prognosis, and treatment. Curr Cardiol Rep. 2020;22:169. https://doi.org/10.1007/s11886-020-01420-z .
doi: 10.1007/s11886-020-01420-z pubmed: 33040219 pmcid: 7547967
Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6:219–28. https://doi.org/10.1016/s1470-2045(05)70093-0 .
doi: 10.1016/s1470-2045(05)70093-0 pubmed: 15811617
Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW. Pathology, imaging, and treatment of cardiac tumours. Nat Rev Cardiol. 2017;14:536–49. https://doi.org/10.1038/nrcardio.2017.47 .
doi: 10.1038/nrcardio.2017.47 pubmed: 28436488
Liddy S, McQuade C, Walsh KP, Loo B, Buckley O. The assessment of cardiac masses by cardiac CT and CMR including pre-op 3D reconstruction and planning. Curr Cardiol Rep. 2019;21:103. https://doi.org/10.1007/s11886-019-1196-7 .
doi: 10.1007/s11886-019-1196-7 pubmed: 31367849
Doherty JU, Kort S, Mehran R, Schoenhagen P, Soman P. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease : a report of the American College of Cardiology Appropriate use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons. J Nucl Cardiol. 2019;26:1392–413. https://doi.org/10.1007/s12350-019-01751-7 .
doi: 10.1007/s12350-019-01751-7 pubmed: 31250324
Fussen S, De Boeck BW, Zellweger MJ, Bremerich J, Goetschalckx K, Zuber M, et al. Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours. Eur Heart J. 2011;32:1551–60. https://doi.org/10.1093/eurheartj/ehr104 .
doi: 10.1093/eurheartj/ehr104 pubmed: 21498848
Lichtenberger JP 3rd, Dulberger AR, Gonzales PE, Bueno J, Carter BW. MR imaging of cardiac masses. Top Magn Reson Imaging. 2018;27:103–11. https://doi.org/10.1097/rmr.0000000000000166 .
doi: 10.1097/rmr.0000000000000166 pubmed: 29613965
Pazos-López P, Pozo E, Siqueira ME, García-Lunar I, Cham M, Jacobi A, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 2014;7:896–905. https://doi.org/10.1016/j.jcmg.2014.05.009 .
doi: 10.1016/j.jcmg.2014.05.009 pubmed: 25129516
Chan AT, Fox J, Perez Johnston R, Kim J, Brouwer LR, Grizzard J, et al. Late gadolinium enhancement cardiac magnetic resonance tissue characterization for cancer-associated cardiac masses: metabolic and prognostic manifestations in relation to whole-body positron emission tomography. J Am Heart Assoc. 2019;8:e011709. https://doi.org/10.1161/jaha.118.011709 .
doi: 10.1161/jaha.118.011709 pubmed: 31072171 pmcid: 6585339
Mousavi N, Cheezum MK, Aghayev A, Padera R, Vita T, Steigner M, et al. Assessment of cardiac masses by cardiac magnetic resonance imaging: histological correlation and clinical outcomes. J Am Heart Assoc. 2019;8:e007829. https://doi.org/10.1161/jaha.117.007829 .
doi: 10.1161/jaha.117.007829 pubmed: 30616453 pmcid: 6405700
Qin C, Shao F, Hu F, Song W, Song Y, Guo J, et al. (18)F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study. Eur J Nucl Med Mol Imaging. 2020;47:1083–93. https://doi.org/10.1007/s00259-019-04632-w .
doi: 10.1007/s00259-019-04632-w pubmed: 31807883
Rahbar K, Seifarth H, Schäfers M, Stegger L, Hoffmeier A, Spieker T, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med. 2012;53:856–63. https://doi.org/10.2967/jnumed.111.095364 .
doi: 10.2967/jnumed.111.095364 pubmed: 22577239
Nensa F, Tezgah E, Poeppel TD, Jensen CJ, Schelhorn J, Köhler J, et al. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study. J Nucl Med. 2015;56:255–60. https://doi.org/10.2967/jnumed.114.147744 .
doi: 10.2967/jnumed.114.147744 pubmed: 25552667
Hod N, Shalev A, Levin D, Anconina R, Ezroh Kazap D, Lantsberg S. FDG PET/CT of cardiac angiosarcoma with pulmonary metastases. Clin Nucl Med. 2018;43:744–6. https://doi.org/10.1097/rlu.0000000000002215 .
doi: 10.1097/rlu.0000000000002215 pubmed: 30036249
Liu C, Zhao Y, Yin Z, Hu T, Ren J, Wei J, et al. Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy: a case report and literature review. Medicine (Baltimore). 2018;97:e11588. https://doi.org/10.1097/md.0000000000011588 .
doi: 10.1097/md.0000000000011588
Zeitouni M, Calais J, Ghodbane W, Ou P, Sannier A, Bouleti C. A cardiac myxoma with intense metabolic activity. Can J Cardiol. 2018;34:92.e11–2. https://doi.org/10.1016/j.cjca.2017.10.010 .
doi: 10.1016/j.cjca.2017.10.010
Dulin M, Pasi N, Benali K, Ducrocq G, Roriz M, Pellenc Q, et al. Management of patients with myocardial tuberculosis: a case series. Int J Cardiol. 2021;327:132–7. https://doi.org/10.1016/j.ijcard.2020.11.001 .
doi: 10.1016/j.ijcard.2020.11.001 pubmed: 33166586
Lau JMC, Raptis DA, Laforest R, Nensa F, Zheng J, Gropler RJ, et al. Cardiac positron emission tomography-magnetic resonance imaging: current status and future directions. J Thorac Imaging. 2018;33:139–46. https://doi.org/10.1097/rti.0000000000000327 .
doi: 10.1097/rti.0000000000000327 pubmed: 29489584
Bruckmann NM, Kirchner J, Umutlu L, Fendler WP, Seifert R, Herrmann K, et al. Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients. Eur Radiol. 2021;31:8714–24. https://doi.org/10.1007/s00330-021-07956-0 .
doi: 10.1007/s00330-021-07956-0 pubmed: 33912991 pmcid: 8523471
Queiroz MA, Ortega CD, Ferreira FR, Nahas SC, Cerri GG, Buchpiguel CA. Diagnostic accuracy of FDG-PET/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients. Eur J Nucl Med Mol Imaging. 2021;48:186–95. https://doi.org/10.1007/s00259-020-04911-x .
doi: 10.1007/s00259-020-04911-x pubmed: 32561971
Virarkar M, Ganeshan D, Devine C, Bassett R Jr, Kuchana V, Bhosale P. Diagnostic value of PET/CT versus PET/MRI in gynecological malignancies of the pelvis: a meta-analysis. Clin Imaging. 2020;60:53–61. https://doi.org/10.1016/j.clinimag.2019.11.018 .
doi: 10.1016/j.clinimag.2019.11.018 pubmed: 31864201
Yeh CH, Chan SC, Lin CY, Yen TC, Chang JT, Ko SF, et al. Comparison of (18)F-FDG PET/MRI, MRI, and (18)F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2020;47:94–104. https://doi.org/10.1007/s00259-019-04510-5 .
doi: 10.1007/s00259-019-04510-5 pubmed: 31606831

Auteurs

Nidaa Mikail (N)

Department of Nuclear Medicine, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. nidaa.mikail@aphp.fr.
Paris Diderot University, Inserm, 1148, Paris, France. nidaa.mikail@aphp.fr.
Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland. nidaa.mikail@aphp.fr.
Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland. nidaa.mikail@aphp.fr.

Lisa Males (L)

Paris Diderot University, Inserm, 1148, Paris, France.
Department of Cardiovascular Imaging, Department of Radiology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Fabien Hyafil (F)

Department of Nuclear Medicine, DMU IMAGINA, Hopital Européen Georges-Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France.

Khadija Benali (K)

Department of Nuclear Medicine, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
Paris Diderot University, Inserm, 1148, Paris, France.

Lydia Deschamps (L)

Department of Pathology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Eric Brochet (E)

Department of Cardiology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Carsten Ehmer (C)

Paris Diderot University, Inserm, 1148, Paris, France.
Department of Cardiovascular Imaging, Department of Radiology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Ahmed Ben Driss (AB)

Paris Diderot University, Inserm, 1148, Paris, France.
Department of Cardiovascular Imaging, Department of Radiology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Loukbi Saker (L)

Paris Diderot University, Inserm, 1148, Paris, France.
Department of Cardiovascular Imaging, Department of Radiology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Alexia Rossi (A)

Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.

Soleiman Alkhoder (S)

Department of Cardiac Surgery, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Richard Raffoul (R)

Department of Cardiac Surgery, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

François Rouzet (F)

Department of Nuclear Medicine, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
Paris Diderot University, Inserm, 1148, Paris, France.

Phalla Ou (P)

Paris Diderot University, Inserm, 1148, Paris, France.
Department of Cardiovascular Imaging, Department of Radiology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH